Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Diabetic Cardiovascular Complications With Vitamin E 400 IU Treatment to High Risk Patients by Haptoglobin Phenotype (I CARE - Israel Cardiovascular Atherosclerosis Risk and Vitamin E)

NCT00220831 is registered in ClinicalTrials.gov with Technion, Israel Institute of Technology as lead sponsor.

NCT NCT00220831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00220831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Diabetic Cardiovascular Complications With Vitamin E 400 IU Treatment to High Risk Patients by Haptoglobin Phenotype (I CARE - Israel Cardiovascular Atherosclerosis Risk and Vitamin E)
Lead sponsor
Technion, Israel Institute of Technology
Phase
Phase 2/3
Overall status
Terminated
Start date
April 30, 2005
Completion date
December 31, 2009
Enrollment
2,000
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, diabetes, myocardial infarction